These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

519 related articles for article (PubMed ID: 28465158)

  • 1. Measles Virus Hemagglutinin epitopes immunogenic in natural infection and vaccination are targeted by broad or genotype-specific neutralizing monoclonal antibodies.
    Muñoz-Alía MA; Casasnovas JM; Celma ML; Carabaña J; Liton PB; Fernandez-Muñoz R
    Virus Res; 2017 May; 236():30-43. PubMed ID: 28465158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigenic Drift Defines a New D4 Subgenotype of Measles Virus.
    Muñoz-Alía MÁ; Muller CP; Russell SJ
    J Virol; 2017 Jun; 91(11):. PubMed ID: 28356529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epitope dampening monotypic measles virus hemagglutinin glycoprotein results in resistance to cocktail of monoclonal antibodies.
    Lech PJ; Tobin GJ; Bushnell R; Gutschenritter E; Pham LD; Nace R; Verhoeyen E; Cosset FL; Muller CP; Russell SJ; Nara PL
    PLoS One; 2013; 8(1):e52306. PubMed ID: 23300970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measles Virus Hemagglutinin Protein Epitopes: The Basis of Antigenic Stability.
    Tahara M; Bürckert JP; Kanou K; Maenaka K; Muller CP; Takeda M
    Viruses; 2016 Aug; 8(8):. PubMed ID: 27490564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of a More Immunogenic Measles Vaccine by Increasing Its Hemagglutinin Expression.
    Julik E; Reyes-Del Valle J
    J Virol; 2016 Jun; 90(11):5270-5279. PubMed ID: 26984727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measles viruses of genotype H1 evade recognition by vaccine-induced neutralizing antibodies targeting the linear haemagglutinin noose epitope.
    Finsterbusch T; Wolbert A; Deitemeier I; Meyer K; Mosquera MM; Mankertz A; Santibanez S
    J Gen Virol; 2009 Nov; 90(Pt 11):2739-2745. PubMed ID: 19625457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional and structural characterization of neutralizing epitopes of measles virus hemagglutinin protein.
    Tahara M; Ito Y; Brindley MA; Ma X; He J; Xu S; Fukuhara H; Sakai K; Komase K; Rota PA; Plemper RK; Maenaka K; Takeda M
    J Virol; 2013 Jan; 87(1):666-75. PubMed ID: 23115278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probing neutralizing-antibody responses against emerging measles viruses (MVs): immune selection of MV by H protein-specific antibodies?
    Santibanez S; Niewiesk S; Heider A; Schneider-Schaulies J; Berbers GAM; Zimmermann A; Halenius A; Wolbert A; Deitemeier I; Tischer A; Hengel H
    J Gen Virol; 2005 Feb; 86(Pt 2):365-374. PubMed ID: 15659756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccine-induced neutralizing antibodies bind to the H protein of a historical measles virus.
    Zemella A; Beer K; Ramm F; Wenzel D; Düx A; Merkel K; Calvignac-Spencer S; Stern D; Dorner MB; Dorner BG; Widulin N; Schnalke T; Walter C; Wolbert A; Schmid BG; Mankertz A; Santibanez S
    Int J Med Microbiol; 2024 Mar; 314():151607. PubMed ID: 38367508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody neutralization of retargeted measles viruses.
    Lech PJ; Pappoe R; Nakamura T; Tobin GJ; Nara PL; Russell SJ
    Virology; 2014 Apr; 454-455():237-46. PubMed ID: 24725950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of immune responses induced by intramuscular vaccination with DNA vaccines encoding measles virus hemagglutinin and/or fusion proteins.
    Song MK; Vindurampulle CJ; Capozzo AV; Ulmer J; Polo JM; Pasetti MF; Barry EM; Levine MM
    J Virol; 2005 Aug; 79(15):9854-61. PubMed ID: 16014946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful vaccine-induced seroconversion by single-dose immunization in the presence of measles virus-specific maternal antibodies.
    Schlereth B; Rose JK; Buonocore L; ter Meulen V; Niewiesk S
    J Virol; 2000 May; 74(10):4652-7. PubMed ID: 10775601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoglobulin g antibody-mediated enhancement of measles virus infection can bypass the protective antiviral immune response.
    Iankov ID; Pandey M; Harvey M; Griesmann GE; Federspiel MJ; Russell SJ
    J Virol; 2006 Sep; 80(17):8530-40. PubMed ID: 16912303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A hemagglutinin-derived peptide-vaccine ignored by virus-neutralizing passive antibodies, protects against murine measles encephalitis.
    El Kasmi KC; Theisen D; Brons NH; Ammerlaan W; Klingele M; Truong AT; Muller CP
    Vaccine; 1999 May; 17(19):2436-45. PubMed ID: 10392626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic and antigenic characterisation of the haemagglutinin protein of measles virus strains recently circulating in the UK.
    Jin L; Knowles WA; Rota PA; Bellini WJ; Brown DW
    Virus Res; 1998 May; 55(1):107-13. PubMed ID: 9712517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depletion of measles virus glycoprotein-specific antibodies from human sera reveals genotype-specific neutralizing antibodies.
    de Swart RL; Yüksel S; Langerijs CN; Muller CP; Osterhaus ADME
    J Gen Virol; 2009 Dec; 90(Pt 12):2982-2989. PubMed ID: 19710253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of neutralizing antibody titers against outbreak-associated measles genotypes (D4, H1 and B3) in Iran.
    Fatemi Nasab GS; Salimi V; Abbasi S; Adjami Nezhad Fard F; Mokhtari Azad T
    Pathog Dis; 2016 Nov; 74(8):. PubMed ID: 27777263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Recombinant Measles Vaccine with Enhanced Resistance to Passive Immunity.
    Julik E; Reyes-Del Valle J
    Viruses; 2017 Sep; 9(10):. PubMed ID: 28934110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection against measles virus encephalitis by monoclonal antibodies binding to a cystine loop domain of the H protein mimicked by peptides which are not recognized by maternal antibodies.
    Ziegler D; Fournier P; Berbers GA; Steuer H; Wiesmüller KH; Fleckenstein B; Schneider F; Jung G; King CC; Muller CP
    J Gen Virol; 1996 Oct; 77 ( Pt 10)():2479-89. PubMed ID: 8887481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective immunity in macaques vaccinated with a modified vaccinia virus Ankara-based measles virus vaccine in the presence of passively acquired antibodies.
    Stittelaar KJ; Wyatt LS; de Swart RL; Vos HW; Groen J; van Amerongen G; van Binnendijk RS; Rozenblatt S; Moss B; Osterhaus AD
    J Virol; 2000 May; 74(9):4236-43. PubMed ID: 10756037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.